Developing and validating a human laboratory model to screen medications for smoking cessation

Nicotine and Tobacco Research

Volumn 14, Issue 11, 2012, Pages 1362-1371

  Mckee, Sherry A ^a   Weinberger, Andrea H ^a   Shi, Julia ^a   Tetrault, Jeanette ^a   Coppola, Sabrina ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO; VARENICLINE;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REINFORCEMENT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AFFECT; FEMALE; HUMANS; MALE; MIDDLE AGED; SELF ADMINISTRATION; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868137115     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts090     Document Type: Article

References (46)

1. Ashare, R. L., & McKee, S. A. (2012). Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Experimental and Clinical Psychopharmacology, 20, 63-70. doi:10.1037/a0025594
2. Ashare, R. L., Sinha, R., Lampert, R., Weinberger, A. H., Anderson, G. M., Lavery, M. E., et al. (2011). Blunted vagal reactivity predicts stress-precipitated tobacco smoking. Psychopharmacology. Advance online publication. doi:10.1007/s00213-011-2473-3
3. Baker, T. B., Piper, M. E., McCarthy, D. E., Bolt, D. M., Smith, S. S., Kim, S. Y., et al. (2007). Time to fi rst cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research, 9 (Suppl. 4), S555-S570. doi:10.1080/14622200701673480
4. Biener, L., & Abrams, D. B. (1991). The contemplation ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.
5. Borland, R., Yong, H.-H., O' Connor, R. J., Hyland, A., & Thompson, M. E. (2010). The reliability and predictive validity of the Heaviness of Smoking Index and its two components: Findings from the International Tobacco Control Four Country study. Nicotine & Tobacco Research, 12, S45-S50. doi:10.1093/ntr/ntq038
6. Brandon, T. H., Tiffany, S. T., Obremski, K. M., & Baker, T. B. (1990). Post cessation cigarette use: The process of relapse. Addictive Behaviors, 15, 105-114.
7. Chornock, W. M., Stitzer, M. L., Gross, J., & Leischow, S. (1992). Experimental model of smoking re-exposure: Effects on relapse. Psychopharmacology, 108, 495-500. doi:10.1007/BF02247427
8. Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, 7-16. doi:10.1080/14622200020032051
9. Dale, L. C., Glover, E. D., Sachs, D. P., Schroeder, D. R., Offord, K. P., Croghan, I. T., et al. (2001). Bupropion for smoking cessation: Predictors of successful outcome. Chest, 119, 1357-1364. doi:10.1378/chest.119.5.1357
10. Del Boca, F. K., Kranzler, H. R., Brown, J., & Korner, P. F. (1996). Assessment of medication compliance in alcoholics through UV light detection of a ribofl avin tracer. Alcohol Clinical & Experimental Research, 20, 1412-1417. doi:10.1111/j.1530-0277.1996.tb01142.x
11. Drobes, D. J., & Tiffany, S. T. (1997). Induction of smoking urges through imaginal and in vivo procedures: Physiological and self-report manifestations. Journal of Abnormal Psychology, 106, 15-25.
12. Fagan, P., Moolchan, E. T., Hart, A., Jr ., Rose, A., Lawrence, D., Shavers, V. L., et al. (2010). Nicotine dependence and quitting behaviors among menthol and non-menthol smokers with similar consumptive patterns. Addiction, 105, 55-74. doi:10.1111/j.1360-0443.2010.03190.x
13. Fidler, J. A., Shahab, L., & West, R. (2011). Strength of urges to smoke as a measure of severity of cigarette dependence: Comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction, 106, 631-638. doi:10.1111/j.1360-0443.2010.03226.x
14. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV, Patient Edition. Washington, DC: American Psychiatric Press.
15. Fu, M., Fernández, E., Pascual, J. A., Martínez-Sánchez, J. M., Agudo, A., Moncada, A., et al. (2011). Stages of change, smoking characteristics, and cotinine concentrations in smokers: Setting priorities for smoking cessation. Preventive Medicine, 52, 139-145. doi:10.1016/j.ypmed.2010.12.003
16. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., et al. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55. doi:10.1001/jama.296.1.47
17. Hariharan, M., Van Noord, T., & Greden, J. F. (1988). A high performance liquid chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clinical Chemistry, 34, 724-729.
18. Harrison, E. L., Coppola, S., & McKee, S. A. (2009). Nicotine deprivation and trait impulsivity affect smokers ' performance on cognitive tasks of inhibition and attention. Experimental and Clinical Psychopharmacology, 17, 91-98. doi:10.1037/a0015657
19. Hatsukami, D., Lexau, G., Nelson, D., Pentel, P. R., Sofuoglu, M., & Goldman, A. (1998). Effects of cotinine on cigarette selfadministration. Psychopharmacology, 138, 184-189.
20. Hatsukami, D. K., Hughes, J. F., Pickens, R. W., & Svikis, D. (1984). Tobacco withdrawal symptoms: An experimental analysis. Psychopharmacology, 84, 231-236.
21. Heatherton, T. F., Kozlowski, L. K., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
22. Hughes, J. F., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
23. Izard, C. E. (1972). Patterns of emotions: A new analysis of anxiety and depression. London: Academic Press.
24. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., et al. (2006). Effi cacy of varenicline, an alpha-4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 396, 56-63. doi:10.1001/jama.296.1.56
25. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685-691.
26. Juliano, L. M., Donny, E. C., Houtsmuller, E. J., & Stitzer, M. L. (2006). Experimental evidence for a causal relationship between smoking lapse and relapse. Journal of Abnormal Psychology, 115, 166-173. doi:10.1037/0021-843X.115.1.166
27. Lerman, C., LeSage, M. G., Perkins, K. A., O ' Malley, S. S., Siegel, S. J., Benowitz, N. L., et al. (2007). Translational research in medication development for nicotine dependence. Nature Reviews: Drug Discovery, 6, 746-762. doi:10.1038/nrd2361
28. Litten, R. Z., Fertig, J. B., Falk, D. E., Ryan, M. L., Mattson, M. E., Collins, J. F., et al. (2012). A double-blind, placebo-controlled trial to assess the effi cacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcoholism: Clinical & Experimental Research, 36, 406-416.
29. Luo, Z., Alvarado, G. F., Hatsukami, D. K., Johnson, E. O., Bierut, L. J., & Breslau, N. (2008). Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). Nicotine & Tobacco Research, 10, 1223-1230. doi:10.1080/14622200802163266
30. McKee, S. A. (2009). Developing human laboratory models of smoking lapse behavior for medication screening. Addiction Biology, 14, 99-107. doi:10.1111/j.1369-1600.2008.00135.x
31. McKee, S. A. (2011, February). Guanfacine attenuates the effect of stress on smoking lapse behavior and improves smoking cessation outcomes. Annual Meeting for the Society for Research on Nicotine and Tobacco, Toronto, Canada.
32. McKee, S. A., Krishnan-Sarin, S., Shi, J., Mase, T., & O'Malley, S. S. (2006). Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology, 189, 201-210. doi:10.1007/s00213-006-0551-8
33. McKee, S. A., Sinha, R., Weinberger, A. H., Sofuoglu, M., Harrison, E. L. R., Lavery, M., et al. (2011). Stress decreases the ability to resist smoking and potentiates smoking reward. Journal of Psychopharmacology, 25, 490-502. doi:10.1177/0269881110376694
34. Niaura, R., Abrams, D., Demuth, B., Pinto, R., & Monti, P. (1989). Responses to smoking-related stimuli and early relapse to smoking. Addictive Behaviors, 14, 419-428. doi:10.1016/0306-4603(89)90029-4
35. Nides, M., Glover, E. D., Reus, V. I., Christen, A. G., Make, B. J., Billing, C. B., Jr ., et al. (2008). Varenicline versus bupropion SR or placebo for smoking cessation: A pooled analysis. American Journal of Health Behavior, 32, 664-675.
36. Perkins, K. A., Broge, M., Gerlach, D., Cherry, C., & Wilson, A. (2002). Acute nicotine reinforcement not chronic tolerance predicts withdrawal and relapse after quitting smoking. Health Psychology, 21, 332-339. doi:10.1037/0278-6133.21.4.332
37. Perkins, K. A., Fonte, C., Meeker, J., White, W., & Wilson, W. (2001). The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behavioural Pharmacology, 12, 35-44.
38. Perkins, K. A., Fonte, C., Sanders, M., White, W., & Wilson, A. (1999). Effects of training dose and two- versus three-choice testing procedure on nicotine discrimination in humans. Psychopharmacology, 145, 418-425.
39. Perkins, K. A., Lerman, C., Fonte, C. A., Mercincavage, M., Stitzer, M. L., Chengappa, K. N., et al. (2010). Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clinical Pharmacology & Therapeutics, 88, 109-114. doi:10.1038/clpt.2010.65
40. Perkins, K. A., Lerman, C., Stitzer, M., Fonte, C. A., Briski, J. L., Scott, J. A., et al. (2008). Development of procedures for early screening of smoking cessation medications in humans. Clinical Pharmacology & Therapeutics, 84, 216-221. doi:10.1038/clpt. 2008.30
41. Perkins, K. A., Saners, M., D ' Amico, D., & Wilson, A. (1997). Nicotine discrimination and self-administration in humans as a function of smoking status. Psychopharmacology, 131, 361-370.
42. Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996). First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting & Clinical Psychology, 64, 366-379.
43. Steinberg, M. B., Bover, M. T., Richardson, D. L., Schmelzer, A. C., Williams, J. M., & Foulds, J. (2011). Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug and Alcohol Dependence, 114, 77-81. doi:10.1016/j.drugalcdep.2010.06.022
44. Toll, B. A., Cooney, N. L., McKee, S. A., & O ' Malley, S. S. (2005). Do daily interactive voice response reports of smoking behavior correspond with retrospective reports? Psychology of Addictive Behaviors, 19, 291-295. doi:10.1037/0893-164X.19.3.291
45. West, E. C., Levin, E. D., & Rose, J. D. (1992). Smoking while wearing the nicotine patch: Is smoking satisfying or harmful? Journal of Clinical Research, 40, 871A.
46. West, R., Baker, C. L., Cappelleri, J. C., & Bushmakin, A. G. (2008). Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology, 197, 371-377. doi:10.1007/s00213-007-1041-3